|
TBP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66533453693773E-15 |
| Normal-vs-Stage2 |
7.38789995846645E-09 |
| Normal-vs-Stage3 |
3.79696274421804E-14 |
| Normal-vs-Stage4 |
3.74000830305476E-12 |
| Stage1-vs-Stage2 |
6.036000E-01 |
| Stage1-vs-Stage3 |
7.565900E-02 |
| Stage1-vs-Stage4 |
8.442300E-02 |
| Stage2-vs-Stage3 |
5.056400E-01 |
| Stage2-vs-Stage4 |
3.952600E-01 |
| Stage3-vs-Stage4 |
7.699400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.66640000001761E-06 |
| Normal-vs-Asian |
8.24789999964715E-07 |
| Caucasian-vs-AfricanAmerican |
5.069400E-01 |
| Caucasian-vs-Asian |
7.677800E-02 |
| AfricanAmerican-vs-Asian |
5.668200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.29816166097407E-14 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
5.911200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6304735339645E-12 |
| Normal-vs-Age(41-60Yrs) |
2.83217893581877E-13 |
| Normal-vs-Age(61-80Yrs) |
1.677880057116E-12 |
| Normal-vs-Age(81-100Yrs) |
1.27920000003723E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.819200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.013000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.076300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.788600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.414400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.790360E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.105970E-02 |
| Classical-VS-Follicular |
4.370200E-02 |
| Classical-VS-Other |
2.714000E-01 |
| Classical-VS-Normal |
1.63113966777928E-12 |
| Tall-VS-Follicular |
3.683000E-01 |
| Tall-VS-Other |
8.933000E-01 |
| Tall-VS-Normal |
5.07160979879018E-12 |
| Follicular-VS-Other |
8.197800E-01 |
| Follicular-VS-Normal |
1.91130444804344E-11 |
| Other-VS-Normal |
6.554200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46549439250521E-13 |
| Normal-vs-N1 |
2.63670196787302E-11 |
| N0-vs-N1 |
3.639200E-01 |
|
|
